The tele-heath market in India is expected to touch US $ 5.4 billion by 2025 and the adoption of tele-health has accelerated with the onset of Covid-19 in 2020. We caught up with Jeya Kumar, Founder and MD, RaphaCure, a prominent player in this segment and he outlined the opportunities that lie ahead for this segment
The company has 47 ANDA's pending approval with the U.S.FDA
Market data indicates that more than twenty percent of the new chemical entities being developed use roller compaction technology in their development and commercialization
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
ICICI Direct gives a preview on the earnings narrative for Q3FY22
The stability is led by healthy demand in the domestic and emerging markets
Under the terms of the agreement, Arrakis will lead research activities for the identification of RNA-targeted small molecule (rSM) binders against a broad set of targets nominated by Amgen
Ind-Ra expects revenue growth of over 12% in 2022.
This service benefits pharmaceutical and fine chemical companies looking to optimise their reactions
Victor Chang Cardiac Research Institute (VCCRI) researcher recognized for his influential work on cardiovascular disease
Subscribe To Our Newsletter & Stay Updated
